Stocks and Investing Stocks and Investing
Fri, May 3, 2024
[ 12:00 AM ] - WOPRAI
Julian Mitchell Maintained (SWK) at Buy with Decreased Target to $100 on, May 3rd, 2024
[ 12:00 AM ] - WOPRAI
Joseph O"Dea Maintained (SWK) at Hold with Decreased Target to $92 on, May 3rd, 2024
[ 12:00 AM ] - WOPRAI
Mike Dahl Maintained (SUM) at Hold with Increased Target to $46 on, May 3rd, 2024
[ 12:00 AM ] - WOPRAI
Trey Grooms Maintained (SUM) at Buy with Increased Target to $50 on, May 3rd, 2024
[ 12:00 AM ] - WOPRAI
Gil Blum Reiterated (STTK) at Strong Buy and Held Target at $12 on, May 3rd, 2024
[ 12:00 AM ] - WOPRAI
Michael Legg Reiterated (SXI) at Strong Buy and Held Target at $190 on, May 3rd, 2024
[ 12:00 AM ] - WOPRAI
Christopher Kuhn Reiterated (SNDR) at Strong Buy and Held Target at $27 on, May 3rd, 2024
[ 12:00 AM ] - WOPRAI
Gabe Hajde Maintained (SON) at Hold with Increased Target to $57 on, May 3rd, 2024
[ 12:00 AM ] - WOPRAI
Neil Kalton Maintained (SO) at Hold with Increased Target to $77 on, May 3rd, 2024
[ 12:00 AM ] - WOPRAI
Richard Anderson Upgraded (DOC) to Buy on, May 3rd, 2024
Thu, May 2, 2024
[ 12:00 AM ] - WOPRAI
Chris Carey Maintained (SMG) at Buy with Decreased Target to $83 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Jake Bartlett Maintained (SYY) at Strong Buy with Decreased Target to $87 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Lauren Lieberman Maintained (TAP) at Hold with Decreased Target to $62 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Sanjay Sakhrani Upgraded (SYF) to Buy and Increased Target to $62 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Atif Malik Maintained (SWKS) at Strong Sell with Decreased Target to $83 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Nathan Martin Reiterated (SXC) at Strong Buy and Held Target at $12 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Colleen Kusy Initiated (syre) at Buy and Held Target at $50 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Matt Miksic Maintained (SYK) at Buy with Increased Target to $376 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Joseph Pantginis Reiterated (STTK) at Strong Buy and Held Target at $28 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Aaron Hecht Reiterated (SUI) at Buy and Held Target at $150 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Katja Jancic Maintained (CENX) at Hold with Increased Target to $16 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Mark Astrachan Maintained (CELH) at Strong Buy with Decreased Target to $85 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Arvind Ramnani Maintained (day) at Hold with Decreased Target to $68 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Raimo Lenschow Maintained (day) at Hold with Decreased Target to $62 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Scott Berg Reiterated (day) at Strong Buy and Held Target at $82 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Mark Moskowitz Maintained (CDW) at Hold with Decreased Target to $232 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Samik Chatterjee Maintained (CDW) at Buy with Decreased Target to $265 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Matthew Sheerin Maintained (CDW) at Strong Buy with Decreased Target to $250 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Asiya Merchant Maintained (CDW) at Strong Buy with Decreased Target to $260 on, May 2nd, 2024
[ 12:00 AM ] - WOPRAI
Bill Sutherland Maintained (CCRN) at Strong Buy with Decreased Target to $19 on, May 2nd, 2024

Bill Sutherland Maintained (CCRN) at Strong Buy with Decreased Target to $19 on, May 2nd, 2024


Published on 2024-10-28 10:54:37 - WOPRAI, Bill Sutherland
  Print publication without navigation


Bill Sutherland of Benchmark, Maintained "Cross Country Healthcare, Inc." (CCRN) at Strong Buy with Decreased Target from $21 to $19 on, May 2nd, 2024.

Bill has made no other calls on CCRN in the last 4 months.



There are 2 other peers that have a rating on CCRN. Out of the 2 peers that are also analyzing CCRN, 1 agrees with Bill's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Tobey Sommer of "Truist Securities" Maintained at Hold with Decreased Target to $16 on, Thursday, February 22nd, 2024


This is the rating of the analyst that currently disagrees with Bill

  • Kevin Steinke of "Barrington Research" Maintained at Buy with Decreased Target to $24 on, Tuesday, February 27th, 2024
Contributing Sources